BlackRock Investment Management, LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 107 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2016. The put-call ratio across all filers is 0.42 and the average weighting 0.7%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q4 2016$2,164,000
-5.8%
77,162
-0.3%
0.00%0.0%
Q3 2016$2,298,000
+47.3%
77,368
+0.4%
0.00%
+50.0%
Q2 2016$1,560,000
+160.4%
77,036
+132.0%
0.00%
+100.0%
Q1 2016$599,000
-30.5%
33,202
+1.5%
0.00%0.0%
Q4 2015$862,000
+24.2%
32,708
+0.6%
0.00%0.0%
Q3 2015$694,000
-21.2%
32,525
-2.2%
0.00%0.0%
Q2 2015$881,00033,2480.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2016
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders